Cargando…
Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction
BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment el...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104372/ https://www.ncbi.nlm.nih.gov/pubmed/27832202 http://dx.doi.org/10.1371/journal.pone.0166240 |
_version_ | 1782466732504383488 |
---|---|
author | Tabata, Noriaki Sueta, Daisuke Akasaka, Tomonori Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Izumiya, Yasuhiro Yamamuro, Megumi Tsujita, Kenichi Kojima, Sunao Kaikita, Koichi Morita, Kazunori Oniki, Kentaro Saruwatari, Junji Nakagawa, Kazuko Hokimoto, Seiji |
author_facet | Tabata, Noriaki Sueta, Daisuke Akasaka, Tomonori Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Izumiya, Yasuhiro Yamamuro, Megumi Tsujita, Kenichi Kojima, Sunao Kaikita, Koichi Morita, Kazunori Oniki, Kentaro Saruwatari, Junji Nakagawa, Kazuko Hokimoto, Seiji |
author_sort | Tabata, Noriaki |
collection | PubMed |
description | BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. METHODS: We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. RESULTS: The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04–0.12 vs. 0.02–0.05; P<0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with ST-segment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23–4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was 0.70 (P<0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). CONCLUSIONS: The coincidence of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction. |
format | Online Article Text |
id | pubmed-5104372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51043722016-12-08 Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction Tabata, Noriaki Sueta, Daisuke Akasaka, Tomonori Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Izumiya, Yasuhiro Yamamuro, Megumi Tsujita, Kenichi Kojima, Sunao Kaikita, Koichi Morita, Kazunori Oniki, Kentaro Saruwatari, Junji Nakagawa, Kazuko Hokimoto, Seiji PLoS One Research Article BACKGROUND: Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. METHODS: We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. RESULTS: The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04–0.12 vs. 0.02–0.05; P<0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with ST-segment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23–4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was 0.70 (P<0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). CONCLUSIONS: The coincidence of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction. Public Library of Science 2016-11-10 /pmc/articles/PMC5104372/ /pubmed/27832202 http://dx.doi.org/10.1371/journal.pone.0166240 Text en © 2016 Tabata et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Tabata, Noriaki Sueta, Daisuke Akasaka, Tomonori Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Izumiya, Yasuhiro Yamamuro, Megumi Tsujita, Kenichi Kojima, Sunao Kaikita, Koichi Morita, Kazunori Oniki, Kentaro Saruwatari, Junji Nakagawa, Kazuko Hokimoto, Seiji Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title | Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title_full | Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title_fullStr | Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title_full_unstemmed | Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title_short | Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction |
title_sort | helicobacter pylori seropositivity in patients with interleukin-1 polymorphisms is significantly associated with st-segment elevation myocardial infarction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104372/ https://www.ncbi.nlm.nih.gov/pubmed/27832202 http://dx.doi.org/10.1371/journal.pone.0166240 |
work_keys_str_mv | AT tabatanoriaki helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT suetadaisuke helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT akasakatomonori helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT arimayuichiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT sakamotokenji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT yamamotoeiichiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT izumiyayasuhiro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT yamamuromegumi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT tsujitakenichi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT kojimasunao helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT kaikitakoichi helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT moritakazunori helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT onikikentaro helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT saruwatarijunji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT nakagawakazuko helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction AT hokimotoseiji helicobacterpyloriseropositivityinpatientswithinterleukin1polymorphismsissignificantlyassociatedwithstsegmentelevationmyocardialinfarction |